Cardiovascular Specialists of Southwest Louisiana is a group of board-certified cardiologists who offer patients in Southwest Louisiana experienced, comprehensive cardiac care with a focus on prevention and early intervention.


We offer a complete range of diagnostic and treatment services for cardiovascular disease including both non-invasive and interventional procedures. Our commitment to innovation, education and personalized care ensure that our patients are receiving the best possible care available.


Please visit us often for the latest developments in cardiovascular care.

Dr. Jake LeBeau Earns Interventional Cardiology Board Certification

Dr. Jake LeBeau, Cardiologist with Cardiovascular Specialists, an affiliate of Imperial Health, has been awarded Board Certification in Interventional Cardiology by the American Board of Internal Medicine. Board certification is a voluntary step in an intensive educational experience that recognizes a physician’s knowledge, skills and experience integral to the delivery of high standards in patient care in their chosen field. They are required to meet rigorous standards through intensive study, self-assessment, skill demonstration and evaluation. This is Dr. LeBeau’s fifth board certification. He has previously been awarded board certified in internal medicine, cardiovascular disease, nuclear cardiology and comprehensive echocardiography.  He is also a registered peripheral vascular interpreter.


A Lake Charles native, Dr. LeBeau earned a Bachelor of Science degree in biomedical engineering from Texas A&M University and a medical degree from Baylor College of Medicine. He completed a residency in internal medicine at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, before pursuing a fellowship in cardiovascular medicine at the University of Texas Health Science Center in Houston, Texas. He then completed an additional fellowship in interventional cardiology at William Beaumont Hospital in Royal Oak, Michigan. Dr. LeBeau is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology, and comprehensive echocardiography. He is also a registered peripheral vascular interpreter.


Dr. LeBeau is a member of the American College of Cardiology, American Heart Association and American Medical Association.  He joined Cardiovascular Specialists in 2014 and is a member of the medical staff of CHRISTUS St. Patrick Hospital and West Calcasieu Cameron Hospital. His office is located at 501 Dr. Michael DeBakey Drive, 3rd Floor.  To schedule an appointment with Dr. LeBeau, call (337) 312-8281.

Interventional Cardiologist, Dr. Thomas Mulhearn, Uses First Lutonix ® Drug-Coated Balloon in SWLA First and only FDA-approved DCB now available for patients

Lake Charles, LA –Interventional Cardiologist, Dr. Thomas Mulhearn, utilized the first Lutonix ®  Drug Coated Balloon PTA Catheter (DCB) in Southwest Louisiana in a procedure performed at CHRISTUS St. Patrick Hospital last week.


CHRISTUS St. Patrick Hospital is proud to bring this technology to SWLA. Lutonix ®  Drug Coated Balloon PTA Catheter (DCB), the first and only Drug Coated Balloon approved by the U.S. Food and Drug Administration (FDA) for minimally invasive treatment of peripheral arterial disease (PAD). 


Peripheral Arterial Disease (PAD) in the femoropopliteal artery, a life-threatening condition, affects millions of Americans by narrowing arteries and reducing blood flow to the limbs, according to American Heart Association (AHA) estimates. Patients with PAD in the femoropopliteal arteries are at risk for lower-extremity amputation, particularly in people over the age of 50. Minimally-invasive endovascular procedures such as angioplasty balloons and stents, medications and vascular bypass surgery are some of the accepted ways to treat PAD, but these options may be limited depending on the type of arterial blockage.


Successful treatment of PAD requires improved blood flow (patency) for longer periods of time. A recent clinical study demonstrated superior primary patency with the Lutonix ® Drug Coated Balloon for the efficacy endpoint.  The LUTONIX® balloon is coated with a drug that prevents re-narrowing of the treated artery to improve long-term results for patients with PAD.


“We are committed to bringing innovations in care to our patients, keeping them here at home for their healthcare, and we are excited to be the first hospital in Southwest Louisiana to offer this new treatment option to our patients,” said Dr. Thomas Mulhearn. “The Lutonix ® Drug Coated Balloon is a new first-line therapy for treating blockages without closing the door to other treatment options down the road, an important consideration as we help our patients manage this painful, progressive and debilitating disease.”


For more information about this new treatment option or any cardiovascular problem, call (337) 436-3813. 

Network activated for rural cardiac patients

VIDEO: story from kplctv.com (June 2013)

The Wrist May Provide a Safer Route to the Heart

As a general rule, people undergoing heart catheterizations in the United States do so with the procedure starting at the femoral artery found in the groin. However, local interventional cardiologist Dr. Thomas Mulhearn with Cardiovascular Specialists is using a new technique that accesses the pathway to the heart through the wrist. (Read more.)

Dr. Mulhearn: To the Heart Through the Wrist

VIDEO: story from kplctv.com (July 2012)

Dr. Turner: Prevention of Heart Disease

VIDEO: From Christus St. Patrick Regional Heart Center's HealthSource




Disclaimer: The intent and purpose of this website is for educational usage only. If you are concerned that you may have a medical condition or experiencing any symptoms that could indicate a medical condition, contact your physician of record immediately or go to your local emergency center for treatment.